Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
Gomides APM, de Albuquerque CP, Santos ABV, Amorim RBC, Bértolo MB, Júnior PL, Santos IA, Giorgi RDN, Sacilotto NC, Radominski SC, Borghi FM, Guimarães MFBR, Pinto MRDC, Resende GG, Bonfiglioli KR, Silva HCD, Sauma MFLDC, Sauma ML, de Medeiros JB, Pereira IA, de Castro GRW, Brenol CV, Xavier RM, da Mota LMH, Pinheiro GDRC. Gomides APM, et al. Among authors: pereira ia. PLoS One. 2019 Mar 1;14(3):e0213219. doi: 10.1371/journal.pone.0213219. eCollection 2019. PLoS One. 2019. PMID: 30822348 Free PMC article.
Potential drug interactions in patients with rheumatoid arthritis.
Bagatini F, Blatt CR, Maliska G, Trespash GV, Pereira IA, Zimmermann AF, Storb BH, Farias MR. Bagatini F, et al. Among authors: pereira ia. Rev Bras Reumatol. 2011 Jan-Feb;51(1):20-39. Rev Bras Reumatol. 2011. PMID: 21412604 English, Portuguese.
The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
da Mota LM, Dos Santos Neto LL, de Carvalho JF, Pereira IA, Burlingame R, Ménard HA, Laurindo IM. da Mota LM, et al. Among authors: pereira ia. Rheumatol Int. 2012 Dec;32(12):3807-12. doi: 10.1007/s00296-011-2260-9. Epub 2011 Dec 21. Rheumatol Int. 2012. PMID: 22187055
Baseline HAQ and SF-36 questionnaire scores cannot predict clinical remission, radiographic progression or the need for biological therapy in a three-year prospective study of a Brazilian early rheumatoid arthritis cohort.
da Mota LM, Dos Santos Neto LL, Oliveira AC, Pereira IA, Burlingame RW, Ménard HA, Laurindo IM. da Mota LM, et al. Among authors: pereira ia. Rheumatol Int. 2012 Dec;32(12):3937-43. doi: 10.1007/s00296-011-2261-8. Epub 2011 Dec 25. Rheumatol Int. 2012. PMID: 22198690
Gender characterization in a large series of Brazilian patients with spondyloarthritis.
de Carvalho HM, Bortoluzzo AB, Gonçalves CR, da Silva JA, Ximenes AC, Bértolo MB, Ribeiro SL, Keiserman M, Menin R, Skare TL, Carneiro S, Azevedo VF, Vieira WP, Albuquerque EN, Bianchi WA, Bonfiglioli R, Campanholo C, Costa IP, Duarte AP, Gavi MB, Kohem CL, Leite NH, Lima SA, Meirelles ES, Pereira IA, Pinheiro MM, Polito E, Resende GG, Rocha FA, Santiago MB, Sauma Mde F, Sampaio-Barros PD; Brazilian Registry on Spondyloarthritis. de Carvalho HM, et al. Among authors: pereira ia. Clin Rheumatol. 2012 Apr;31(4):687-95. doi: 10.1007/s10067-011-1890-3. Epub 2011 Dec 28. Clin Rheumatol. 2012. PMID: 22203094
2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis.
da Mota LM, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, de Freitas MV, da Silva NA, Louzada-Júnior P, Giorgi RD, Lima RA, da Rocha Castelar Pinheiro G; Brazilian Society of Rheumatology. da Mota LM, et al. Among authors: pereira ia. Rev Bras Reumatol. 2012 Mar-Apr;52(2):152-74. Rev Bras Reumatol. 2012. PMID: 22460407 English, Portuguese.
243 results